Reviewing Globus Medical (GMED) & Integer Holdings (ITGR)
Globus Medical (NYSE: GMED) and Integer Holdings (NASDAQ:ITGR) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitabiliy and valuation.
Institutional and Insider Ownership
69.5% of Globus Medical shares are owned by institutional investors. 28.2% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Risk and Volatility
Globus Medical has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, Integer Holdings has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500.
This is a breakdown of recent recommendations and price targets for Globus Medical and Integer Holdings, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Globus Medical presently has a consensus target price of $29.50, indicating a potential downside of 0.30%. Integer Holdings has a consensus target price of $35.00, indicating a potential downside of 24.24%. Given Globus Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe Globus Medical is more favorable than Integer Holdings.
This table compares Globus Medical and Integer Holdings’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation & Earnings
This table compares Globus Medical and Integer Holdings’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Globus Medical||$595.44 million||3.59||$206.08 million||$1.11||26.66|
|Integer Holdings||$1.41 billion||1.03||$275.03 million||N/A||N/A|
Integer Holdings has higher revenue and earnings than Globus Medical.
Globus Medical beats Integer Holdings on 9 of the 13 factors compared between the two stocks.
Globus Medical Company Profile
Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.
Integer Holdings Company Profile
Greatbatch, Inc. is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise. Greatbatch Medical’s products include medical devices and components for the cardiac, neuromodulation, orthopedics, portable medical, vascular and energy markets. QiG focuses on developing medical device systems for some of healthcare’s challenges and reflects the Company’s strategic evolution of its product offerings in order to raise the growth and profitability profile of the Company. QiG utilizes a diversified portfolio approach with three investment modes: new medical device systems commercialization, collaborative programs with OEM customers and strategic equity positions in emerging healthcare companies.
Receive News & Ratings for Globus Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.